Core Viewpoint - Two Seas Capital LP opposes the proposed sale of Core Scientific to CoreWeave, arguing that the transaction undervalues Core Scientific and is based on a flawed process [1][2][3] Valuation Analysis - Two Seas presents a detailed valuation analysis indicating that the proposed transaction offers inadequate value to Core Scientific shareholders, who possess valuable high-performance computing assets [2][3] - The firm highlights that Core Scientific's peers have seen their values more than double in the three months since the announcement of the deal, while Core Scientific's stock has declined due to its association with CoreWeave's underperforming stock [3] Shareholder Action - Two Seas urges Core Scientific shareholders to vote against the proposed transaction using the GOLD proxy card ahead of the special meeting scheduled for October 30, 2025 [2][9] - The firm emphasizes that alternatives to the proposed transaction are superior and encourages shareholders to review their presentation for a comprehensive understanding [4]